Gilead Sciences, Inc. Financials

Market Capitalization $150.88 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	19.00
Forward PE	14.04
Price to Sales TTM	$5.24
Price to Book MRQ	$7.08
Enterprise to Revenue	5.80
Enterprise to EBITDA	11.93

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-09-30
Profit Margin	27.88%
Operating Margin	45.23%
Return on Assets TTM	12.57%
Return on Equity TTM	40.71%

Income Statement

Revenue TTM	$29,087,000,576
Revenue per Share TTM	$23.35
Quarterly Revenue Growth	3.00%
Gross Profit TTM	$22,896,001,024
EBITDA	$14,261,000,000
Net Income to Common TTM	$8,110,000,128
Diluted EPS TTM	$6.46
Quarterly Earnings Growth YoY	143.60%

Balance Sheet

Total Cash MRQ	$8,489,999,872
Total Cash per Share MRQ	$6.84
Total Debt MRQ	$
Total Debt to Equity MRQ	116.24
Current Ratio MRQ	1.45
Book Value per Share MRQ	$17.34

Cash Flow

Operating Cash Flow TTM	$9,667,000,320
Levered Free Cash Flow TTM	$8,028,000,256

GILD Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	1,242,000,000
Float Shares	1,238,036,975
Avg 10 Volume	6,375,920
Avg 30 Volume	None
Shares Short	21,650,110
Short Ratio	3.04
Short % of Shares	1.75%
% Held by Insiders	0.10%
% Held by Institutions	91.59%

Stock Price Summary

Beta	0.33
Fifty Two Week Low	$88.57
Fifty Two Week High	$128.70
Fifty Two Week Change	24.83%
Day 50 MA	$122.85
Day 200 MA	$113.65

Dividends and Splits

Forward Annual Dividend Rate	$3.16
Forward Annual Dividend Yield	2.60%
Trailing Annual Dividend Rate	$3.16
Trailing Annual Dividend Yield	2.60%
Payout Ratio	48.61%
Dividend Date	2025-12-30
Ex Dividend Date	2025-12-15
Last Split Factor
Last Split Date	2013-01-28